AMPH FY 2024 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMPHAmphastar Pharmaceuticals, Inc.

$894M

FY 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$732M+13.6% YoY

Gross Profit

$374M51.1% margin

Operating Income

$205M28.1% margin

Net Income

$160M21.8% margin

EPS (Diluted)

$3.06

Cash Flow

Operating Cash Flow

$213M

Free Cash Flow

$172M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$845M

Stockholders' Equity

$732M

Cash & Equivalents

$152M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$732M	$644M	+13.6%
Gross Profit	$374M	$351M	+6.5%
Operating Income	$205M	$197M	+4.3%
Net Income	$160M	$138M	+16.0%